Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,639 | -24,230 | -53,533 | -8,193 | 1,873 |
| Depreciation Amortization | 1,566 | 803 | 2,158 | 5,510 | 3,975 |
| Accounts receivable | N/A | -3,050 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -4,502 | N/A | N/A | N/A |
| Other Working Capital | -11,601 | -16,090 | 42,377 | -34,732 | -20,205 |
| Other Operating Activity | 5,987 | 11,693 | 1,536 | 2,177 | 1,856 |
| Operating Cash Flow | $-59,687 | $-35,377 | $-7,462 | $-35,238 | $-12,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 8,109 | N/A | N/A | N/A |
| PPE Investments | -158 | -66 | -423 | -218 | -337 |
| Other Investing Activity | 8,405 | -126 | 10,378 | 22,547 | 69 |
| Investing Cash Flow | $8,247 | $7,917 | $9,955 | $22,329 | $-268 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -5,059 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 16,951 | N/A | N/A | N/A |
| Other Financing Activity | 6,868 | 0 | -6,501 | -2,128 | -1,359 |
| Financing Cash Flow | $6,868 | $11,892 | $-6,501 | $-2,128 | $-1,359 |
| Exchange Rate Effect | 1,235 | 1,160 | -546 | 297 | 158 |
| Beginning Cash Position | 75,120 | 75,373 | 76,402 | 91,157 | 91,839 |
| End Cash Position | 31,783 | 60,965 | 71,847 | 76,416 | 77,870 |
| Net Cash Flow | $-43,337 | $-14,408 | $-4,555 | $-14,741 | $-13,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,687 | -35,377 | -7,462 | -35,238 | -12,501 |
| Capital Expenditure | N/A | -66 | N/A | N/A | N/A |
| Free Cash Flow | -59,687 | -35,443 | -7,462 | -35,238 | -12,501 |